Table V.
Total number, percentages (between parentheses), and statistical significance of BPPV recurrency and thyroid autoantibodies in the entire sample and in subsamples of males (M) and females (F) with onset of the first BPPV below 40, between 40 and 60 and over 60.
| Recurrent BPPV | Autoantibodies | |
|---|---|---|
| Mtot (n = 703) | 439 (62.5%) | 72 (10.2%) |
| Ftot (n = 2339) | 1609 (68.8%) | 731 (31.2%) |
| p | 0.001 | < 0.00001 |
| M<40 (n = 98) | 67 (68.4%) | 8 (8.1%) |
| F<40 (n = 443) | 346 (78.1%) | 135 (30.5%) |
| p | 0.04 | < 0.00001 |
| M40-60 (n = 306) | 205 (67%) | 49 (16%) |
| F40-60 (n = 1172) | 823 (70.2%) | 386 (32.9%) |
| p | ns | < 0.00001 |
| M≥60 (n = 299) | 167 (55.8%) | 49 (16%) |
| F≥60 (n = 724) | 440 (60.8%) | 210 (29%) |
| p | ns | 0.00002 |